Work

Abstract 4366569: Proprotein Convertase Subtilisin/ Kexin Type 9 Inhibitors Improve Lipid Profile and May Stabilize Vasculopathy in Heart Transplant Recipients with Chronic Allograft Vasculopathy: A Pooled Analysis of Existing Studies

Cites:
Cited by:
Related to: